Published on 17/12/2025
Mastering Regulatory Meeting Request Formats: Compliance-Ready Guide for Sponsors and RA Teams
Introduction to Meeting Request Formats and Their Importance
Meeting request formats are standardized templates used by sponsors and regulatory affairs teams to engage with health authorities such as the FDA, EMA, and CDSCO. These requests cover scientific advice, pre-submission consultations, pre-IND/CTA meetings, and Type A/B/C meetings. A well-structured meeting request ensures regulators understand the purpose, scope, and context of the engagement, improving the likelihood of approval and timely feedback.
By 2025, regulatory meetings have become strategic opportunities for sponsors to clarify requirements, reduce submission risks, and accelerate approvals. Meeting request formats are therefore essential tools for compliance, transparency, and proactive regulatory engagement.
Key Concepts and Regulatory Definitions
Different regulators use specific terms and structures for meetings:
- FDA Type A Meeting: Urgent meetings addressing stalled development or clinical holds.
- FDA Type B Meeting: Pre-IND, pre-NDA, or end-of-phase meetings.
- FDA Type C Meeting: Other product-specific development discussions.
- EMA Scientific Advice: Meetings with the Scientific Advice Working Party (SAWP) to discuss trial design and development plans.
- CDSCO Pre-Submission Meeting: Consultation to discuss dossier requirements and clinical trial protocols.
- Briefing Package: A companion document provided to regulators, outlining
These definitions emphasize why meeting request formats must be aligned with regulatory authority expectations and standardized templates.
Applicable Guidelines and Global Frameworks
Meeting request formats align with several key frameworks:
- FDA Guidance on Formal Meetings (2017): Defines content and format of meeting requests and briefing documents.
- EMA Scientific Advice Guidance: Provides templates for applications to SAWP.
- CDSCO Guidelines: Outline procedures for pre-submission meetings in India.
- ICH E6 (R2/R3) GCP: Ensures discussions are aligned with ethical and scientific principles.
- WHO Guidance: Encourages early regulator-sponsor dialogue for global development programs.
This framework ensures regulatory meetings are consistent, transparent, and documented for future reference.
Processes, Workflow, and Submissions
Preparing and submitting meeting requests follows a defined process:
- Determine Meeting Type: Identify whether the request is pre-IND, pre-CTA, scientific advice, or a lifecycle meeting.
- Prepare Draft Request: Use authority-specific templates outlining objectives, proposed agenda, and questions.
- Develop Briefing Package: Compile supporting data, including nonclinical, clinical, or CMC information.
- Internal Review: Cross-functional teams review draft documents for clarity and compliance.
- Submit Request: File via FDA ESG, EMA’s IRIS portal, or CDSCO submission systems.
- Regulatory Acceptance: Authorities review and confirm meeting date or provide feedback.
- Meeting Conduct: Sponsor presents topics, addresses regulator queries, and documents agreements.
- Follow-Up: Sponsors submit meeting minutes to confirm agreements and next steps.
This workflow ensures structured and successful regulatory interactions.
Sample Meeting Request Format
Below is a sample outline of a meeting request format:
| Section | Content |
|---|---|
| Header | Company details, product name, IND/CTA/MAA number |
| Type of Meeting | FDA Type B, EMA Scientific Advice, or CDSCO Pre-Submission |
| Objectives | Purpose of the meeting, including regulatory clarification sought |
| Proposed Agenda | List of topics/questions for discussion |
| Supporting Data | References to nonclinical, clinical, or quality information |
| Requested Attendees | Company representatives, regulatory experts, requested agency attendees |
| Attachments | Briefing package, draft protocol, or supporting analyses |
Using such formats ensures regulators receive all essential details upfront, minimizing review delays.
Tools, Software, or Templates Used
Meeting request preparation is supported by several tools:
- Authority Templates: FDA meeting request template, EMA SAWP application forms, CDSCO forms.
- Document Management Systems: Veeva Vault, MasterControl for drafting and approval workflows.
- Publishing Tools: FDA ESG and EMA IRIS for electronic submissions.
- Checklists: Internal checklists ensuring completeness of meeting request packages.
- Collaboration Tools: MS Teams, Zoom, and secure platforms for pre-meeting preparation.
These tools ensure accurate, timely, and compliant meeting requests across regions.
Common Challenges and Best Practices
Meeting requests present several challenges for regulatory teams:
- Incomplete Packages: Missing briefing documents delay regulator acceptance.
- Ambiguous Objectives: Poorly defined questions limit value of regulator feedback.
- Timelines: Late submission may miss regulatory deadlines for meeting slots.
- Inconsistent Communication: Lack of alignment between internal teams and regulator expectations.
Best practices include drafting requests early, aligning objectives with development strategy, preparing clear and concise questions, and rehearsing with cross-functional teams. Regulatory intelligence should be leveraged to anticipate agency expectations.
Latest Updates and Strategic Insights
By 2025, regulatory meetings and request formats are shaped by evolving trends:
- Digital Submissions: Online portals like FDA ESG and EMA IRIS standardize meeting request submissions.
- Hybrid Meetings: Regulators increasingly conduct meetings virtually or in hybrid formats.
- Global Harmonization: ICH exploring unified approaches for regulatory authority engagement.
- Transparency: Agencies publishing anonymized meeting outcomes to improve consistency.
- Inspection Focus: Authorities reviewing meeting request formats during audits to confirm compliance with communication procedures.
Strategically, organizations must treat meeting request formats as strategic tools for regulatory alignment. Sponsors that prepare robust, well-structured meeting requests gain clearer guidance, reduce risks of rejections, and accelerate approvals.
Conclusion
Meeting request formats are essential for effective engagement with regulatory authorities. By aligning with FDA, EMA, and CDSCO requirements, using standardized templates, and adopting best practices, sponsors can ensure clear, timely, and successful communication. In 2025 and beyond, regulatory meeting requests will remain key to shaping development strategies, ensuring compliance, and building strong regulator-sponsor relationships.